Market cap
₹30 Cr
Revenue (TTM)
₹325 Cr
P/E Ratio
483.5
P/B Ratio
0.4
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | 1.08 | 6.45 | 3.19 |
| EBIT | -- | -- | -39.76 | -24.93 | -12.38 |
| Net Profit | -- | -- | 33.56 | 11.16 | 7.17 |
| EPS | -- | -- | 33.56 | -54.98 | -37.69 |
| Book Value | -- | -- | 2.96 | -28.26 | -14.86 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-25 | Mar-24 | Mar-23 |
| EBIT-Margin
| 3.05 | 3.14 | 1.26 | 2.11 | 5.77 |
| Net Margin
| 1.16 | 0.88 | 0.69 | 0.52 | 2.26 |
| Return on equity
| 15.66 | 13.24 | 3.09 | 3.67 | 40.22 |
| Return on Capital
| 13.77 | 15.07 | 6.65 | 8.60 | 26.08 |
| Return on Assets
| 3.59 | 2.84 | 1.67 | 1.49 | 7.62 |
| Debt to Equity (x)
| -- | -- | 0.61 | 0.68 | 2.78 |
Profitability
ROCE
6.65
Lower than Peers by 8.61
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Cell Point (India)
|
6.65
|
8.60
|
26.08
|
18.29
|
15.75
|
|
Peer Median
|
15.26
|
13.09
|
18.25
|
0.63
|
--
|
ROE
3.09
Lower than Peers by 9.69
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Cell Point (India)
|
3.09
|
3.67
|
40.22
|
13.13
|
6.08
|
|
Peer Median
|
12.78
|
10.28
|
17.00
|
0.54
|
--
|
ROA
1.67
Lower than Peers by 4.35
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Cell Point (India)
|
1.67
|
1.49
|
7.62
|
2.24
|
1.16
|
|
Peer Median
|
6.01
|
3.85
|
3.31
|
0.48
|
--
|
EBIT Margin
1.26
Lower than Peers by 3.57
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Cell Point (India)
|
1.26
|
2.11
|
5.77
|
3.59
|
2.96
|
|
Peer Median
|
4.83
|
--
|
10.55
|
3.06
|
--
|
Net Margin
0.69
Lower than Peers by 1.90
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Cell Point (India)
|
0.69
|
0.52
|
2.26
|
0.61
|
0.31
|
|
Peer Median
|
2.59
|
1.30
|
4.04
|
2.62
|
--
|
Cash Profit Margin
1.69
Higher than Peers by 1.69
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Cell Point (India)
|
1.69
|
1.11
|
2.59
|
1.03
|
0.85
|
|
Peer Median
|
0.00
|
--
|
0.00
|
0.00
|
--
|
Revenue Growth
1.08
--
Year on year growth in net sales
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Cell Point (India)
|
1.08
|
8.65
|
9.85
|
20.69
|
-19.65
|
|
Peer Median
|
--
|
--
|
1,14,672.74
|
377.44
|
--
|
EBIT Growth
-39.76
Lower than Peers by 786.61
Year on year growth in operating profit (EBIT)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Cell Point (India)
|
-39.76
|
-60.20
|
76.45
|
46.74
|
-16.84
|
|
Peer Median
|
746.85
|
--
|
379.32
|
253.14
|
--
|
Net Profit Growth
33.56
Lower than Peers by 1,986.02
Year on year growth in profit after tax
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Cell Point (India)
|
33.56
|
-74.82
|
308.50
|
138.21
|
-56.80
|
|
Peer Median
|
2,019.58
|
--
|
45,857.95
|
202.20
|
--
|
EPS Growth
33.56
Lower than Peers by 1,986.03
Year on year growth in earnings per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Cell Point (India)
|
33.56
|
-81.60
|
-62.86
|
138.21
|
-56.80
|
|
Peer Median
|
2,019.58
|
--
|
--
|
202.25
|
--
|
Book Value Growth
2.96
--
Year on year growth in book value per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Cell Point (India)
|
2.96
|
259.07
|
50.34
|
14.06
|
6.27
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.61
Higher than Peers by 0.31
Total debt / Net worth
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Cell Point (India)
|
0.61
|
0.68
|
2.78
|
3.87
|
3.29
|
|
Peer Median
|
0.30
|
0.83
|
0.18
|
0.00
|
--
|
Short term debt to equity ratio
0.59
--
(Short term borrowings / Net worth)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Cell Point (India)
|
0.59
|
0.65
|
1.71
|
1.98
|
1.14
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.26
Lower than Peers by 0.63
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Cell Point (India)
|
1.26
|
1.18
|
1.08
|
1.01
|
1.08
|
|
Peer Median
|
1.89
|
2.12
|
2.32
|
9.82
|
--
|
Quick Ratio
0.24
Lower than Peers by 3.07
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Cell Point (India)
|
0.24
|
0.27
|
0.26
|
0.26
|
0.21
|
|
Peer Median
|
3.32
|
--
|
10.44
|
1.86
|
--
|
Interest Coverage
1.54
Lower than Peers by 10.13
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Cell Point (India)
|
1.54
|
1.47
|
2.16
|
1.30
|
1.22
|
|
Peer Median
|
11.67
|
2.84
|
15.56
|
4.90
|
--
|
Operating Efficiency
Debtors to sales
0.36
Lower than Peers by 18.66
Debtors outstanding / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Cell Point (India)
|
0.36
|
0.12
|
0.04
|
0.17
|
0.11
|
|
Peer Median
|
19.03
|
--
|
37.72
|
35.45
|
--
|
Asset Turnover
2.39
Lower than Peers by 0.86
Sales / Average Total Assets
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Cell Point (India)
|
2.39
|
2.82
|
3.35
|
3.67
|
3.74
|
|
Peer Median
|
3.26
|
--
|
2.29
|
1.44
|
--
|
Receivable days
0.89
--
Average Debtors / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Cell Point (India)
|
0.89
|
0.30
|
0.36
|
0.48
|
0.76
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
66.74
--
Average Inventory / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Cell Point (India)
|
66.74
|
57.39
|
51.82
|
43.23
|
37.16
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
15.69
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Cell Point (India)
|
15.69
|
13.71
|
18.44
|
18.87
|
21.53
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
51.94
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Cell Point (India)
|
51.94
|
43.97
|
33.74
|
24.83
|
16.39
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
13.18
Lower than Peers by 2.15
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Cell Point (India)
|
13.18
|
35.48
|
--
|
--
|
--
|
|
Peer Median
|
15.33
|
47.26
|
34.13
|
156.50
|
--
|
Price / Book Value
0.40
Lower than Peers by 1.88
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Cell Point (India)
|
0.40
|
0.83
|
--
|
--
|
--
|
|
Peer Median
|
2.28
|
5.49
|
1.37
|
2.06
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Cell Point (India)
|
--
|
0.78
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
7.73
Lower than Peers by 4.13
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Cell Point (India)
|
7.73
|
9.38
|
3.06
|
3.84
|
4.35
|
|
Peer Median
|
11.86
|
40.42
|
13.39
|
-6.22
|
--
|
Market Cap
30
Lower than Peers by 115
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Cell Point (India)
|
30
|
60
|
--
|
--
|
--
|
|
Peer Median
|
145
|
679
|
176
|
103
|
--
|